Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Protara Therapeutics, Inc. | 60,000 | reported | 18 Jan 2019 | tx 6+196,382 |
| ENANTA PHARMACEUTICALS INC | 3,591 | reported | 12 Feb 2026 | tx 6+320,493−1,902 |
| Sigilon Therapeutics, Inc. | 0 | reported | 11 Aug 2023 | tx 3+165,000−14,615 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 Feb 2026 | GRANT_AWARD | ENANTA PHARMACEUTICALS INC | 4,175 | 0.00 USD | |
| 12 Feb 2026 | GRANT_AWARD | ENANTA PHARMACEUTICALS INC | 1,318 | 0.00 USD | |
| 12 Feb 2026 | TAX_WITHHOLDING | ENANTA PHARMACEUTICALS INC | 1,902 | 14.25 USD | |
| 25 Nov 2025 | GRANT_AWARD | ENANTA PHARMACEUTICALS INC | 90,000 | 0.00 USD | deriv |
| 27 Nov 2024 | GRANT_AWARD | ENANTA PHARMACEUTICALS INC | 75,000 | 0.00 USD | deriv |
| 29 Apr 2024 | GRANT_AWARD | ENANTA PHARMACEUTICALS INC | 150,000 | 0.00 USD | deriv |
| 11 Aug 2023 | OTHER | Sigilon Therapeutics, Inc. | 1,925 | — | |
| 11 Aug 2023 | OTHER | Sigilon Therapeutics, Inc. | 12,690 | 0.75 USD | deriv |
| 28 Feb 2023 | GRANT_AWARD | Sigilon Therapeutics, Inc. | 165,000 | 0.00 USD | deriv |
| 18 Jan 2019 | GRANT_AWARD | Protara Therapeutics, Inc. | 60,000 | 0.00 USD | deriv |
| 31 Dec 2018 | GRANT_AWARD | Protara Therapeutics, Inc. | 2,448 | 1.93 USD | |
| 29 Jun 2018 | GRANT_AWARD | Protara Therapeutics, Inc. | 10,000 | 1.62 USD | |
| 17 Jan 2018 | GRANT_AWARD | Protara Therapeutics, Inc. | 110,000 | 0.00 USD | deriv |
| 29 Dec 2017 | GRANT_AWARD | Protara Therapeutics, Inc. | 3,934 | 1.30 USD | |
| 30 Jun 2017 | GRANT_AWARD | Protara Therapeutics, Inc. | 10,000 | 1.30 USD |